Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials

INTRODUCTION: Heart failure (HF) is still a major cause of morbidity and mortality all over the world. Aim of the study was to assess the benefits and harms of sacubitril/valsartan (S/V) compared to angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez, Adrian V., Pasupuleti, Vinay, Scarpelli, Nancy, Malespini, Jack, Banach, Maciej, Bielecka-Dabrowa, Agata M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Systematic review/Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259398/
https://www.ncbi.nlm.nih.gov/pubmed/37313196
http://dx.doi.org/10.5114/aoms/159113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259398/
https://www.ncbi.nlm.nih.gov/pubmed/37313196
http://dx.doi.org/10.5114/aoms/159113

Ejemplares similares